Molecular glue development continues to gain exponential momentum, with advances in screening tools, identification assays and structure-based design. With numerous strategic collaborations and investments into rationale drug discovery, the molecular glue field is propelling the clinical progression of next-generation molecular glue candidates across a spectrum of indications and undruggable targets.

Owing to this, the 2^nd Molecular Glue Drug Development Summit returned as the world’s only fully molecular glue-dedicated meeting. The conference united 80+ glue experts devoted to accelerating the discovery and development of novel, rationally designed and therapeutically validated glues for patients in need.